High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy

NCT ID: NCT07159022

Last Updated: 2025-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During sedated gastroscopy, the insertion of the fiberscope and gastric distension required to perform the examination may induce respiratory depression, airway obstruction, and decreased chest wall compliance. Patients with obesity, especially visceral fat, have poor lung and chest wall compliance, lower lung capacity and functional residual capacity, and an unbalanced ventilation-to-perfusion ratio. Thus, obese patients are at a high risk of hypoxemia.

Increasing evidence supports the use of High-flow nasal cannula (HFNC) oxygenation in obese patients during sedated gastrointestinal endoscopy. Obesity, especially visceral obesity, is an established risk factor associated with all-cause mortality. Body roundness index (BRI) is a newer anthropometric measure associated with identification of high-risk individuals. Owing to the limited evidence, we designed this unblinded randomized controlled trial to assess whether HFNC, compared to standard mask oxygenation, improves oxygenation at the end of the procedure (primary endpoint) in patients with visceral obesity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

High Flow Nasal Cannula Body Roundness Index

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Flow Nasal Cannula Oxygenation

High Flow Nasal cannula is a system to deliver heated and humidified oxygen with an inspired oxygen fraction between 21 and 100% through large bore nasal cannula. The system delivers a flow up to 60 liters/min.

Group Type EXPERIMENTAL

High Flow Nasal Cannula Oxygenation

Intervention Type PROCEDURE

High Flow Nasal Cannula will be set at 60 liters per minute of air/oxygen admixture to reach a peripheral oxygen saturation equal or greater than 94%

Mask Oxygenation

Conventional Oxygenation will be administered through mask

Group Type ACTIVE_COMPARATOR

Face Mask Oxygenation

Intervention Type PROCEDURE

conventional oxygen therapy will be administered through common mask with a flow up to 6 Liters per minute

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Flow Nasal Cannula Oxygenation

High Flow Nasal Cannula will be set at 60 liters per minute of air/oxygen admixture to reach a peripheral oxygen saturation equal or greater than 94%

Intervention Type PROCEDURE

Face Mask Oxygenation

conventional oxygen therapy will be administered through common mask with a flow up to 6 Liters per minute

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA class ≤Ⅲ
* Visceral obesity(body mass index≥28 and BRI ≥5.46)
* Patients who will undergo sedated gastroscopy

Exclusion Criteria

* Life-threatening heart disease or acute myocardial infarction within 6 weeks
* Presence of pneumothorax or pulmonary bullae, pulmonary embolism, pulmonary oedema
* Upper respiratory tract infection
* Presence of tracheostomy
* Nasal or nasopharyngeal diseases
* Coagulation disorders or a tendency of nose bleeding
* Pregnancy
* Recent (within 1 week) thoracic surgery
* Emergent procedure or surgery
* Allergy to drugs used during the procedure
* Unwillingness to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Zhongshan Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongshan Hospitla

Shanghai, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wenling Zhao

Role: CONTACT

+86-18321299017

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B2025-212

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BEAM for Weight Loss - a Pilot Study
NCT06622382 RECRUITING NA
Laryngeal Masks for Bariatric Surgery
NCT01724970 UNKNOWN PHASE3